SCHEMBL7984208

SCHEMBL7984208

CCc1nc(O)c2c(ncn2Cc2cccc(F)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
THRB P10828 1/20 0.39
BRD4 O60885 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 2/20 0.38
PDE1A P54750 1/20 0.38
PDE1B Q01064 1/20 0.38
PDE1C Q14123 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
DPP4 P27487 1/20 0.38
LMNA P02545 1/20 0.36
DBH P09172 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B13 Q7Z5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988484 0.92 PDE1A (0.43) MAPTTHRBBRD4CYP11B1CYP11B2
SCHEMBL7989501 0.88 CDK9 (0.38) MAPTTHRBBRD4CYP11B1CYP11B2
SCHEMBL7974260 0.87 CYP11B1 (0.47) MAPTCYP11B1CYP11B2ALDH1A1TSHR
SCHEMBL7988533 0.86 TAAR1 (0.43) BRD4CYP11B1CYP11B2HSD17B13EPHX2
SCHEMBL7984754 0.86 SMN1; SMN2 (0.47) BRD4CYP11B1CYP11B2MAPK1KDM4E
SCHEMBL7984526 0.85 MET (0.46) CYP11B1CYP11B2ALDH1A1KDM4EHPGD
SCHEMBL7975252 0.85 HPGD (0.45) CYP11B1CYP11B2ALDH1A1PKMTSHR
SCHEMBL7984497 0.84 MET (0.41) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7984512 0.84 GAA (0.50) MAPTLMNARXFP1GAA
SCHEMBL7985651 0.82 CYP1A2 (0.41) ALDH1A1PKMHPGDSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed